CompoSecure (CMPO) Financials

CompoSecure’s latest statements show a highly unusual financial profile. The company reported $50.3 million of net income in Q2 2026, reversing a $235.0 million loss in Q1. However, the improvement was driven almost entirely by a $67.1 million gain, while reported revenue was $0 and operating expenses remained $9.4 million. Investors should therefore treat the latest earnings figure as heavily influenced by non-operating and potentially non-recurring items.

Operating performance has deteriorated sharply in the available quarterly data. Revenue was approximately $95 million to $109 million per quarter during 2023 and 2024, but the 2025 and 2026 records provided generally show zero revenue, apart from small reported costs. Operating income fell from positive results of $24.9 million to $31.8 million in 2024 and early 2025 to losses of $9.9 million, $55.6 million and $9.4 million in the later reported periods.

Cash generation has also been inconsistent. Operating cash flow was positive in most 2023 and 2024 quarters, including $32.2 million in Q2 2024, but turned negative in Q3 and Q4 2025 and Q1 2026. It recovered to $8.6 million in Q2 2026, although that amount was modest relative to the reported $50.3 million net income. The company’s cash balance was only $7.7 million at June 30, 2026, despite total assets of $3.46 billion.

The balance sheet changed dramatically following major investment and equity transactions. Long-term investments increased from $84.3 million in Q3 2025 to $3.17 billion in Q2 2026, while common equity rose to $3.17 billion. Q1 2026 cash flow included $1.96 billion of common-equity issuance and $2.02 billion of investing outflows. These transactions substantially increased the company’s asset base and equity, but they also make comparisons with earlier periods difficult.

• Q2 2026 net income returned to positive territory: Consolidated net income was $50.3 million, compared with a $235.0 million loss in Q1 2026.
• Operating cash flow improved sequentially: Cash flow from operations rose from negative $52.6 million in Q1 2026 to positive $8.6 million in Q2.
• Liquidity increased modestly during Q2: Cash and equivalents rose from $6.5 million at the end of Q1 to $7.7 million at the end of Q2.
• Reported liabilities declined slightly: Total liabilities fell from $297.8 million in Q1 2026 to $290.1 million in Q2, while total equity increased to $3.17 billion.
• Interest expense was absent in the latest reported quarters: The Q1 and Q2 2026 income statements recorded no interest expense, compared with significant interest costs in 2023 and 2024.
• Asset growth was substantial but difficult to interpret: Long-term investments reached $3.17 billion in Q2 2026 from $84.3 million in Q3 2025, reflecting major transactions rather than gradual operating expansion.
• The statements contain restated and calculated periods: Several 2024 and 2025 figures are marked as restated or calculated, so historical comparisons may change as reporting is updated.
• Revenue reporting has collapsed in the latest periods: The Q1 and Q2 2026 statements show zero operating revenue, compared with more than $100 million in quarterly revenue during much of 2024.
• Latest earnings depend heavily on unusual gains: Q2 net income included $67.1 million of other gains, while the company recorded a $16.8 million pretax loss before that gain.
• Cash coverage remains thin: Q2 cash of $7.7 million was well below current liabilities of $23.7 million, and financing activities used $15.4 million during the quarter.

Overall, the statements suggest that the company’s reported Q2 profit does not yet demonstrate a recovery in its core operating business. The most important issues for investors are whether meaningful revenue resumes, whether operating cash flow remains positive without large financing transactions, and whether the substantial investment balance can produce sustainable returns. The supplied filings identify the company as CompoSecure, Inc. (NYSE: CMPO), rather than Composecure (NYSE: GPGI), so the ticker and issuer should be verified before relying on this analysis.